Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03024437
Title Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Roberto Pili

renal cell carcinoma


Atezolizumab + Entinostat

Atezolizumab + Bevacizumab + Entinostat


Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.